Exchange: TSX·Updated 03:49 PM EDT

About RVX.TSX

About

Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan, and Alzheimer's diseases. The company was founded by Donald J. McCaffrey and Norman C. W. Wong on August 17, 2000 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
17

Frequently Asked Questions

What is Market Cap of Resverlogix Corp.?
What is the 52-week high for Resverlogix Corp.?
What is the 52-week low for Resverlogix Corp.?
What is Resverlogix Corp. stock price today?
What was Resverlogix Corp. stock price yesterday?
What is the PE ratio of Resverlogix Corp.?
What is the Price-to-Book ratio of Resverlogix Corp.?
What is the 50-day moving average of Resverlogix Corp.?
How many employees does Resverlogix Corp. have?

Advertisement|Remove ads.